Stock Research Subscriptions: A Buyer's Guide to What You Get

Annual fee ÷ account value × 100. That percentage is the first number to work out for any research subscription, because it is a drag on returns you pay whether the research is good or bad, and it shrinks as the account grows. Everything else in the decision is about whether the research earns it back.

Run the sum with your own fee and your own balance. Small accounts get a sobering answer.

What these subscriptions sell

The typical bundle has analyst-written reports on individual companies, a rating or recommendation, a fair value or price target, and a layer of data and screening tools. Some add model portfolios. The reports are what you are paying for. A rating or a fair value is a report squeezed into one symbol or one number, so it can never be better than the reasoning it came from, and if you only ever read the stars you are paying for the research without using it.

Can you see how the numbers are made?

Look for a methodology page. It should say how a fair value is reached: which cash flows get projected, over how many years, at what discount rate, and how a rating follows from the gap between the share price and that estimate. Take one report. Find the assumptions that drive its number. If you can do that in a few minutes, the provider is being open with you.

It matters because fair value is a set of assumptions. Nudge the growth rate or the discount rate and the estimate can swing widely, which you can watch happen by entering a few versions of the same company into the DCF calculator and seeing how far apart the answers land. A report that shows its inputs lets you disagree with one of them. One that shows only the output asks for trust.

Ratings need the same scrutiny. What does “buy” or four stars mean here? Over what horizon? How often do ratings change, and is there a record of past ratings you can compare with what the stocks later did? Reading analyst ratings covers the usual scales and how to read them.

Coverage and how often it changes

Take your current holdings and your watchlist to the trial. Search for every name. Sort them into three piles: a full written report, only a data page or an automated summary, and missing altogether. A long coverage list means little if the companies you care about sit in the thin part of it.

Then look at dates. When was each report last revised? A report written before the latest earnings release describes a company as it was a quarter ago, with guidance, margins and sometimes management that may have changed since, so a stale date on a report you were about to act on is a reason to stop and read the new filing yourself. Good providers revise after results and material news. They print the revision date where you can see it.

Conflicts and independence

Ask who pays. Readers alone? Then the incentives are fairly simple. A provider that also earns money from the companies it covers, from running funds, from investment banking work or from trading has other pulls on it, and those belong in a disclosure printed on the report itself. Read the disclosure section at the foot of a few reports. A missing section, or one vague line, is reason to hold the ratings more loosely.

What you can get free

The source documents behind most reports cost nothing. Annual and quarterly reports sit on EDGAR. Earnings releases, slide decks and call recordings go up on company investor relations pages. Learning to read a 10-K takes an afternoon. It pays off on every company you follow.

So the fair test is simple. After reading a paid report, ask whether you learned something you would not have found in the filings and the earnings call in the time you are actually willing to spend, because that gap, and only that gap, is what the fee buys. Sometimes the answer is yes: a good analyst compares a company with peers you had not considered, or spots a change in a footnote. Sometimes the report restates the press release.

Two follow-ups take the next steps. Free and paid ways to get analyst research reports compares the routes to research, from the brokerage account you already have to reports a company paid for, and reading an analyst report in 15 minutes works through one in the order that tells you the most.

Before paying at all, when an equity research subscription pays for itself sets the fee against the size of the account it would guide and the decisions it would have to change.

Red flags on a trial

• No methodology page, or one that describes the process in marketing language with no assumptions shown.
• Fair values with no stated discount rate or growth assumptions anywhere.
• Reports with no revision date, or dates well before the last earnings release.
• No conflict disclosure on the reports themselves.
• Performance claims for the ratings with no benchmark, no time period and no list of the ratings that went wrong.
• A trial that locks the reports and shows only the tools, so you never see the product you would be paying for.
• Renewal terms you can find only in the fine print. Find out what renewal costs and how cancelling works before the trial converts, and put the date in your calendar.

If the service also promotes a stock-picking letter, the checks in the newsletter buyer’s guide apply to that part.

Turning the trial into a score

Score after you have read at least three full reports on companies you know well. Weak analysis shows fastest there. Methodology, coverage and conflicts carry weight 3, since a failure on any one of them makes the research hard to rely on however polished the rest of the product is. The fee row is weighted 2, and your own fee-to-account percentage should set the mark: the larger it is, the lower the score. Tools sit at weight 1. They are easy to find elsewhere.